Target intelligence / Profile preview

X-ray photon absorption in biological tissues by tri-iodinated benzene rings

Molecular classification
Not applicable (this is a physical-chemical mechanism, not a biological molecule), Chemical imaging agent, Contrast enhancement mechanism
01

Overview

This entry describes the physical mechanism by which tri-iodinated benzene rings attenuate x-rays in medical imaging rather than a biological therapeutic target. The tri-iodinated benzene ring is the fundamental chemical structure of iodinated contrast agents (ICAs) used in radiographic imaging, including CT scans and fluoroscopy. The mechanism relies on the atomic radius of covalently bonded iodine atoms (approximately 133 picometers) falling within the wavelength range of diagnostic x-rays (10 to 10,000 picometers), allowing efficient x-ray attenuation. Iodine's high atomic number (Z=53) and k-shell binding energy of 33.2 keV enable strong photoelectric absorption at diagnostic x-ray energies. The three iodine atoms bonded to a benzene ring provide enhanced molecular size for attenuating longer-wavelength x-rays while the covalent bonding to the stable benzene ring reduces toxicity from free iodide. This is a chemical-physical property exploited in contrast media design, not a biological target for drug therapy.

Other names
Tri-iodinated benzene ring x-ray attenuationIodinated contrast agent mechanism2,4,6-triiodinated benzene ring x-ray absorption
02

Mechanism of action

Photoelectric absorption of x-ray photons by iodine atoms (atomic number 53); X-ray attenuation through differential photoelectric absorption; Enhanced radiographic contrast due to iodine's k-shell binding energy (33.2 keV) matching diagnostic x-ray energy ranges

03

Biological functions

Not applicable (this is not a biological target but a radiographic imaging principle)X-ray attenuationPhotoelectric absorption enhancement
04

Disease associations

Not applicable (diagnostic imaging mechanism, not involved in disease pathology)
05

Safety considerations

Not applicable to the mechanism itself, though iodinated contrast agents have associated risks including renal toxicity, allergic reactions, and contrast-induced nephropathy
06

Interacting drugs

Not applicable (this describes the mechanism of iodinated contrast agents themselves, not a target they interact with)
07

Biomarkers

Not applicable

Beyond the preview

Go deeper on X-ray photon absorption in biological tissues by tri-iodinated benzene rings.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on X-ray photon absorption in biological tissues by tri-iodinated benzene rings.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call